Jane Street’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
+20,447
| New | +$151K | ﹤0.01% | 4867 |
|
|
2025
Q1 | – | Sell |
-6,061
| Closed | -$217K | – | 6213 |
|
|
2024
Q4 | $217K | Sell |
6,061
-10,637
| -64% | -$380K | ﹤0.01% | 5010 |
|
|
2024
Q3 | $789K | Buy |
16,698
+4,005
| +32% | +$189K | ﹤0.01% | 3714 |
|
|
2024
Q2 | $638K | Sell |
12,693
-2,132
| -14% | -$107K | ﹤0.01% | 4259 |
|
|
2024
Q1 | $1.66M | Sell |
14,825
-16
| -0.1% | -$1.79K | ﹤0.01% | 2558 |
|
|
2023
Q4 | $861K | Buy |
14,841
+3,921
| +36% | +$227K | ﹤0.01% | 3488 |
|
|
2023
Q3 | $347K | Sell |
10,920
-1,659
| -13% | -$52.7K | ﹤0.01% | 3937 |
|
|
2023
Q2 | $1.03M | Buy |
+12,579
| New | +$1.03M | ﹤0.01% | 3008 |
|
|
2022
Q4 | – | Sell |
-1,337
| Closed | -$226K | – | 5976 |
|
|
2022
Q3 | $226K | Buy |
+1,337
| New | +$226K | ﹤0.01% | 4453 |
|
|
2022
Q2 | – | Sell |
-5,733
| Closed | -$572K | – | 6002 |
|
|
2022
Q1 | $572K | Buy |
5,733
+3,672
| +178% | +$366K | ﹤0.01% | 3585 |
|
|
2021
Q4 | $320K | Buy |
2,061
+236
| +13% | +$36.6K | ﹤0.01% | 3938 |
|
|
2021
Q3 | $430K | Sell |
1,825
-270
| -13% | -$63.6K | ﹤0.01% | 3600 |
|
|
2021
Q2 | $712K | Sell |
2,095
-438
| -17% | -$149K | ﹤0.01% | 3008 |
|
|
2021
Q1 | $1.03M | Sell |
2,533
-800
| -24% | -$324K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $2.22M | Buy |
3,333
+1,931
| +138% | +$1.28M | ﹤0.01% | 1334 |
|
|
2020
Q3 | $653K | Buy |
1,402
+467
| +50% | +$218K | ﹤0.01% | 2202 |
|
|
2020
Q2 | $547K | Buy |
935
+439
| +89% | +$257K | ﹤0.01% | 2456 |
|
|
2020
Q1 | $72K | Buy |
+496
| New | +$72K | ﹤0.01% | 3183 |
|
|
2019
Q3 | – | Sell |
-2,458
| Closed | -$249K | – | 3786 |
|
|
2019
Q2 | $249K | Buy |
2,458
+2,004
| +441% | +$203K | ﹤0.01% | 2930 |
|
|
2019
Q1 | $60K | Buy |
+454
| New | +$60K | ﹤0.01% | 3127 |
|